Autolus Therapeutics PLC (NAS:AUTL)
$ 3.785 -0.055 (-1.43%) Market Cap: 1.01 Bil Enterprise Value: 314.39 Mil PE Ratio: 0 PB Ratio: 1.73 GF Score: 55/100

Autolus Therapeutics PLC at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 16, 2020 / 06:45PM GMT
Release Date Price: $13.94 (+0.94%)
Vikram Purohit
Morgan Stanley, Research Division - Equity Analyst

Great. Welcome, everyone. Let's go ahead and get started. My name is Vikram Purohit. I am one of the research analysts with the Morgan Stanley biotech team, and I have on the line with me Christian Itin with Autolus Therapeutics. Christian, welcome. Thank you for joining us.

Christian Martin Itin
Autolus Therapeutics plc - Chairman & CEO

Thanks for having us.

Vikram Purohit
Morgan Stanley, Research Division - Equity Analyst

Sure. And before we get into our conversation, I just need to read a brief disclosure statement. Please note that this webcast is for Morgan Stanley's clients and appropriate Morgan Stanley employees only. This webcast is not for members of the press. If you are a member of the press, please disconnect and reach out separately. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot